17,500 Insulin-Dependent Gazans Face Critical Shortages as Cold-Chain Collapses

Gaza's blockade has rendered insulin—a mass-produced, globally available drug—inaccessible to some 17,500 people who depend on it daily to survive, including over 1,000 children with type 1 diabetes. The barrier is not scarcity but logistics: restricted goods entry and failed refrigeration infrastructure have disrupted supply chains across two-and-a-half years. The Ministry of Health warned on June 3, 2026 that critical shortages now threaten thousands of patients' lives.